T&R Biofab Co., Ltd. (KOSDAQ:246710)

T&R Biofab Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023
Operating Revenue	9,641	4,874	5,199
Other Revenue	-	-	-0
Revenue	9,641	4,874	5,199
Revenue Growth (YoY)	-	-6.26%	-
Cost of Revenue	7,236	2,766	4,151
Gross Profit	2,406	2,108	1,048
Selling, General & Admin	7,728	7,230	7,024
Research & Development	5,477	5,510	4,399
Other Operating Expenses	190.38	172.15	227.69
Operating Expenses	15,850	15,407	13,902
Operating Income	-13,445	-13,299	-12,853
Interest Expense	-2.64	-2.2	-3.24
Interest & Investment Income	1,227	1,227	1,676
Currency Exchange Gain (Loss)	3.91	7.49	0.97
Other Non Operating Income (Expenses)	8,044	8,044	-1,424
EBT Excluding Unusual Items	-4,173	-4,023	-12,604
Gain (Loss) on Sale of Investments	-505.27	-517.37	5.26
Gain (Loss) on Sale of Assets	-5.8	-5.8	-0.14
Asset Writedown	-	-	-195.49
Other Unusual Items	-640.19	-3,133	-625.01
Pretax Income	-5,325	-7,679	-13,419
Net Income	-5,325	-7,679	-13,419
Net Income to Common	-5,325	-7,679	-13,419
Shares Outstanding (Basic)	22	22	21
Shares Outstanding (Diluted)	22	22	21
Shares Change (YoY)	-	1.59%	-
EPS (Basic)	-246.20	-356.48	-632.85
EPS (Diluted)	-246.20	-356.48	-632.85
Free Cash Flow	-14,741	-14,309	-19,456
Free Cash Flow Per Share	-681.60	-664.29	-917.58
Gross Margin	24.95%	43.24%	20.16%
Operating Margin	-139.45%	-272.87%	-247.22%
Profit Margin	-55.23%	-157.56%	-258.10%
Free Cash Flow Margin	-152.89%	-293.60%	-374.22%
EBITDA	-10,302	-10,895	-10,697
EBITDA Margin	-106.86%	-223.55%	-205.74%
D&A For EBITDA	3,142	2,404	2,156
EBIT	-13,445	-13,299	-12,853
EBIT Margin	-139.45%	-272.87%	-247.22%
Advertising Expenses	-	390.07	267.47

Source: S&P Global Market Intelligence. Standard template. Financial Sources.